Medical Selling And Marketing Expenses from 2010 to 2024

MPW Stock  USD 4.04  0.07  1.70%   
Medical Properties Selling And Marketing Expenses yearly trend continues to be fairly stable with very little volatility. Selling And Marketing Expenses is likely to outpace its year average in 2024. During the period from 2010 to 2024, Medical Properties Selling And Marketing Expenses regression line of quarterly data had mean square error of 1.8 T and geometric mean of  2,833,601. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2009-09-30
Previous Quarter
69.7 M
Current Value
72.2 M
Quarterly Volatility
17.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medical Properties financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Properties' main balance sheet or income statement drivers, such as Depreciation And Amortization of 633.5 M, Interest Expense of 390.6 M or Selling General Administrative of 152.9 M, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.22 or PTB Ratio of 0.37. Medical financial statements analysis is a perfect complement when working with Medical Properties Valuation or Volatility modules.
  
Check out the analysis of Medical Properties Correlation against competitors.

Latest Medical Properties' Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Medical Properties Trust over the last few years. It is Medical Properties' Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medical Properties' overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

Medical Selling And Marketing Expenses Regression Statistics

Arithmetic Mean5,410,872
Geometric Mean2,833,601
Coefficient Of Variation28.45
Mean Deviation721,432
Median5,653,000
Standard Deviation1,539,260
Sample Variance2.4T
Range6.8M
R-Value0.55
Mean Square Error1.8T
R-Squared0.30
Significance0.03
Slope188,817
Total Sum of Squares33.2T

Medical Selling And Marketing Expenses History

20246.8 M
20236.5 M
20115.7 M
2010 129.0

About Medical Properties Financial Statements

Medical Properties investors use historical fundamental indicators, such as Medical Properties' Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medical Properties. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling And Marketing Expenses6.5 M6.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.